Charting the Course of Telehealth in the Post-COVID Landscape
CE Credit: 1
Domain: Legal & Regulatory
This session will discuss fundamental principles and best practices to help ensure that telemedicine systems work in tandem with AI-based insurance systems, comport with regulatory requirements and avoid the potential for malpractice.
COVID-19 required health systems to implement telemedicine services in an exponential way. Federal and state governments rose to the occasion, introducing legislation, regulations and executive orders designed to facilitate the roll-out of telemedicine. However, modalities must ensure that each patient’s privacy rights are protected, while enabling health care providers to render medical care in accordance with professional standards. Insurance companies depend upon artificial intelligence (AI) to process invoices involving telemedicine, so billing systems must be adjusted so that services will be compensated. While the topography may be uncertain, adherence to fundamental principles and best practices will ensure that telemedicine systems work in tandem with AI-based insurance systems, comport with regulatory requirements and avoid the potential for malpractice.
- • Provide an overview of the impact of COVID-19 and the events of 2020-2021 on telemedicine
- • Describe the trend of insurance companies in relying upon artificial intelligence on the processing of claims
- • Identify telemedicine best practices, including adapting new systems for electronic medical records, comporting with privacy requirements and potential professional liability pitfalls
|ASHRM CE Credits||1.0|
|Domain||Legal & Regulatory|
|Level - Foundational (F), Practitioner (P), Advanced (A)||P|
For questions regarding this webinar, contact ASHRMEd@aha.org
Mary Kate is a shareholder at Marshall Dennehey and serves as co-chair of the firm’s Telehealth and Telemedicine Practice Group. She works closely with her clients to help them understand and comply with evolving legal standards in order to reduce exposure and mitigate risk as they incorporate technology into their medical practice. She also handles compliance matters, defending and advising health care clients in issues relating to government payment programs, electronic discovery and privacy matters. Mary Kate has published and presented on recent trends and practicalities of telemedicine, particularly within the context of the COVID-19 pandemic, to the legal and medical communities on a local and national scale.
Jeffrey Rapattoni is a shareholder and member of the Board of Directors at Marshall Dennehey, where he also serves as chair of the firm’s PIP Litigation Practice Group and co-chair of the Fraud/Special Investigation Practice Group. Jeffrey focuses his practice on insurance fraud, bad faith and SIU related matters, working with carriers both in the U.S. and internationally. Jeffrey and his team regularly litigate insurance fraud and fraud-related matters throughout the state of New Jersey. He also coordinates complex litigation strategy and fraud-related investigations throughout all of the firms jurisdictions. Jeffrey has extensive training and background in provider-based investigations, underwriting fraud, policy voidance and staged accidents. Other practice areas include large loss property claims, coverage, general civil litigation, and appellate practice. He also has significant experience in large settlement negotiation, mediation and arbitration.
Adam Fulginiti is a shareholder at Marshall Dennehey. As co-chair of the firm’s Telehealth and Telemedicine Practice Group, he focuses on helping clients navigate the intersection of heath care, technology and the law. Additionally, Adam has an extensive practice in the arena of social services, where he represents foster care and adoption agencies, residential treatment facilities and community social service agencies. Adam has published and presented on recent trends and practicalities of telemedicine, particularly within the context of the COVID-19 pandemic, to the legal and medical communities on a local and national scale.